Integrative Physiology |
From the Institute of Biomedical Research and Department of Physiology, University of Sydney, New South Wales, Australia.
Correspondence to Prof D.G. Allen, Institute of Biomedical Research and Department of Physiology, University of Sydney F-13, New South Wales, 2006 Australia. E-mail davida{at}physiol.usyd.edu.au
| Abstract |
|---|
|
|
|---|
Key Words: Na+/H+ exchanger preconditioning ischemia reperfusion
| Introduction |
|---|
|
|
|---|
-
and ß-adrenergic transmitters, bradykinin, and endothelin (for
review, see Reference 2 ). These triggers bind to
appropriate receptors that are G protein coupled and cause
phospholipase C activation, production of inositol triphosphate
and diacylglycerol, and eventually, activation of protein kinase
C.3 4 Presumably, phosphorylation of some
key proteins then results in protection of the myocardium
from the damaging effects of ischemia and/or reperfusion. This
latter part of the mechanism is the least well-defined. The
ATP-sensitive K+ channel
(KATP) is one of the
phosphorylated proteins that provides protection. The
initial evidence was that blockers of the KATP
channel prevented preconditioning.5 Subsequently, it was
shown that protein kinase C causes phosphorylated
KATP and contributes to its
activation.6 Recently, it has been suggested that it is
the mitochondrial KATP channel that is
involved,7 although the mechanism of protection remains
unclear. To understand how the protection invoked by preconditioning might occur, it is important to understand the possible mechanisms of myocardial damage during ischemia and/or reperfusion. One of the best established pathways is that protons produced during ischemia leave the myocytes on the Na+/H+ exchanger during reperfusion causing Na+ loading. Subsequently, Ca2+ loading occurs as Na+ leaves the cell on the Na+/Ca2+ exchanger. The resulting rise in [Ca2+]i is believed to trigger Ca2+-activated proteases and phospholipases that cause the cellular damage.8 9 In support of this theory is the observation that maneuvers which reduce Ca2+ entry at the time of reperfusion lead to myocardial protection.10 Another important finding is that inhibition of the Na+/H+ exchanger reduces myocardial damage on reperfusion.11 12 13
These findings suggest that coupled activation of the Na+/H+ exchanger and Na+/Ca2+ exchanger in response to intracellular acidosis may be part of the damage mechanism during reperfusion. If this is the case, modulation of this pathway might explain the beneficial effects of preconditioning. One version of this hypothesis was supported by Steenbergen et al. 14 They showed that after preconditioning the acidosis in the long period of ischemia was reduced, presumably because glycogen had been partly consumed in the preconditioning ischemias, and therefore the anaerobic lactic acid production was reduced.15 Consequently, the Na+ accumulation and the Ca2+ accumulation were reduced and the myocardial damage was lessened.14
It has long been suspected that the Na+/H+ exchanger would be inhibited during ischemia,16 and recent studies from our laboratory provide strong support for this view, although suggesting a different mechanism.17 We also established that the Na+/H+ exchanger reactivates rapidly on reperfusion, leading to a rapid rise of [Na+]i. If this rise in [Na+]i was prevented by an Na+/H+ exchange inhibitor, then the damaging effects of ischemia would be prevented. These observations led us to hypothesize that preconditioning might inhibit the Na+/H+ exchanger during reperfusion and prevent myocardial damage by this pathway. In the present study, we have investigated this possibility by means of measurements of [Na+]i and pHi during ischemia and reperfusion.
| Materials and Methods |
|---|
|
|
|---|
5 Hz) and helps to ensure adequate O2
delivery to the cells. Developed pressure (DP) was monitored with a
balloon in the left ventricle.
Fluorescence Measurements
The hearts were placed in a chamber mounted on the stage of an
inverted microscope modified for fluorescence
measurements.17 Briefly, after measuring the
autofluorescence, the hearts were loaded for 40 to 60 minutes
by perfusion with the membrane-permeable acetoxymethyl ester form of
fluorescent indicators for
[Na+]i (SBFI) and for
pHi (SNARF). The fluorescence signals
from SBFI and SNARF were converted to
[Na+]i and
pHi using established calibration
methods.17
Preliminary experiments with SNARF showed that during ischemia there was an initial acidosis of about 1 pH unit over 10 minutes, but after 15 minutes, the pHi showed a tendency to recover. We reasoned that this was because CO2, which is known to accumulate in the heart during ischemia,19 would tend to diffuse out of the epicardial cells into the stagnant solution surrounding the heart. To minimize this effect, we replaced the external solution in the bath with standard Tyrode equilibrated with 70% N2 and 30% CO2 at 10 and 20 minutes. This solution would have the dual effect of preventing any oxidative metabolism in the epicardial cells of the heart and preventing the loss of CO2 from the heart by diffusion. Under these conditions, pHi generally decreased smoothly during ischemia.
Ischemia, Preconditioning, and Drug Treatment
The ischemia was induced by stopping perfusion inflow to
the heart while the heart was maintained at 35°C. The standard period
of ischemia was 30 minutes; preconditioning consisted of 3
periods of 5 minutes of ischemia each followed by 5 minutes
reperfusion and then followed by the standard 30 minutes of
ischemia.
5-(N-methyl-N-isobutyl)amiloride (MIA) and
tetrodotoxin (TTX) were applied 5 minutes before the 30 minutes of
ischemia.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
| Results |
|---|
|
|
|---|
|
|
Figure 1B
illustrates the preconditioning protocol. Note that
the RC is much smaller than in the ischemia-only record and
that DP shows a good recovery. In 5 hearts, there was no significant
difference in either the magnitude of the IC (28±7 mm Hg) or the
time of first appearance (23±3 minutes) compared with ischemia
only. However, the RC was much smaller (16±8 mm Hg) and the
recovery of DP was much greater (75±4%).
To identify possible mechanisms of the elevations of
[Na+]i during
ischemia and on reperfusion, we blocked various
Na+ influx pathways. Inhibitors of
the Na+/H+ exchanger have
been shown to reduce the rise in
[Na+]i during
ischemia,13 to reduce the
[Na+]i during
reperfusion,12 17 and to improve the mechanical recovery
after ischemia.11 12 13 In the experiment shown in
Figure 1C
, the Na+/H+ exchanger
inhibitor MIA (10 µmol/L) was applied 5 minutes
before the start of ischemia. Note that there was little or no
RC in this experiment and the DP showed a substantial recovery. In 5
experiments, the initial 5 minutes of exposure to MIA caused no
significant change in DP (DP after 5 minutes of exposure was 88±6%).
The IC (18±4 mm Hg) was not significantly different than
ischemia whereas the RC (34±6 mm Hg) was significantly
smaller than that during ischemia only. The recovery of DP
(62±9%) was much greater than ischemia alone but not
significantly different than preconditioned hearts.
Another possible source of Na+ influx into
the cell during ischemia is through Na+
channels.21 22 We were particularly interested in the
possibility that a persistent component of the
Na+ channel (INa(P))
might contribute to Na+ influx during
ischemia. There are several reasons for thinking that this
component of Na+ influx might increase during
ischemia. (1) INa(P) is less
inactivated by the depolarized conditions that occur in
ischemia.23 (2)
INa(P) is preferentially increased during
hypoxia.24 To test these ideas, we made use
of the fact that 100 nmol/L TTX almost completely suppresses
INa(P) but has very little effect on the
conventional INa.23
Figure 1D
shows that this concentration of TTX did not prevent
regular contractions, confirming that normal
INa was little affected. A typical IC
developed and a moderately sized RC is apparent, and recovery of DP was
intermediate in size between ischemia only and the enhanced
recovery observed in preconditioning and MIA. In 6 hearts, DP did not
change significantly in the initial 5 minutes of exposure (86±10%),
IC was 31±4 mm Hg, RC was 36±8 mm Hg, and DP recovered to
37±8% (not significantly greater than ischemia only but
significantly smaller than the preconditioned recovery).
[Na+]i During Ischemia and
Reperfusion
Having determined that preconditioning improved the
functional recovery after ischemia in a manner similar to that
produced by inhibition of the
Na+/H+ exchanger, we were
interested in whether changes in
[Na+]i were involved in
these effects. The changes in
[Na+]i during
ischemia and reperfusion under various conditions are
illustrated in Figure 2
and summarized in
Table 2
. Figure 2A
shows a small,
slow rise of [Na+]i
during 30 minutes of ischemia whereas reperfusion caused a
large transient increase of
[Na+]i, which partially
recovered over 20 minutes. Under control conditions,
[Na+]i was 7.2±0.3
mmol/L (n=24). In 6 hearts, the ischemic rise was 3.2±0.9
mmol/L; the increase on reperfusion was +11.9±2.5 mmol/L. Over 30
minutes of reperfusion,
[Na+]i partially
recovered to 13.4±3.0 mmol/L.
|
|
The rise in [Na+]i during ischemia in the present experiments is relatively small, but we showed recently that when the stimulation frequency was higher (5 Hz), the rise of [Na+]i during a 10-minute period of ischemia was larger.17 We therefore measured the rise of [Na+]i during ischemia in 4 hearts paced at 5 Hz. The [Na+]i at 5 Hz was higher (11.5±1.3 mmol/L) than at 2 Hz (7.3±1.2 mmol/L), as expected,25 and after 30 minutes of ischemia, it reached 21.3±3.1 mmol/L, an increase of 9.8±1.6 mmol/L, which was larger than hearts stimulated at 2 Hz. The IC occurred at 7±1 minutes, which was much earlier than the 2-Hz group. Another possible reason that the rise in [Na+]i during ischemia might be smaller in the present experiments is that the extracellular and/or intracellular acidosis might be reduced in myocytes close to the surface (because CO2, which normally accumulates in the heart during ischemia,19 can diffuse into the surrounding perfusate). To prevent this, in 2 experiments we replaced the extracellular solution around the heart during ischemia with one containing 30% CO2 (pHo 6.6). The rise in [Na+]i in 30 minutes of ischemia in these experiments was 6.2±3.5 mmol/L, which is not significantly different than the control group at 2 Hz.
Figure 2B
shows an example of the
[Na+]i record during
preconditioning and the subsequent ischemia and reperfusion.
Note that the 3 short preconditioning ischemias have no
significant effect on
[Na+]i. The increase in
[Na+]i during the
subsequent long ischemia remained small, but a striking
difference is apparent on reperfusion when the
[Na+]i did not rise as in
ischemia only but declined rapidly back to control level. In 5
hearts, the ischemic rise was 4.6±1.0 mmol/L, which is
not significantly different than in ischemia only. The
[Na+]i change on
reperfusion was a fall (-3.6±1.3 mmol/L) to a level that was not
significantly different than the preischemic level.
MIA had no effect on [Na+]i concentration over 5 minutes in control conditions nor any effect on the [Na+]i rise caused by the 30-minute periods of ischemia (4.4±0.6 mmol/L). In the presence of MIA, reperfusion caused an immediate decline in [Na+]i (-3.7±0.9 mmol/L) similar to that observed in the preconditioned heart. This final level was not significantly different than control and did not change thereafter.
TTX treatment (100 nmol/L) had no effect on [Na+]i concentration during the 5-minute application. However, the rise in [Na+]i caused by 30 minutes of ischemia was abolished by TTX treatment (+0.3±0.7 mmol/L). Reperfusion resulted in a relatively large transient increase of [Na+]i (+8.6±3.5 mmol/L), which was not significantly different from that observed during ischemia only. The [Na+]i level slowly declined so that after 30 minutes of reperfusion, [Na+]i concentration was 13.0±1.7 mmol/L, which was still significantly higher than the preischemic [Na+]i level.
pHi Measurements During Ischemia and
Reperfusion
The absence of a rise in
[Na+]i after
preconditioning suggests that the
Na+/H+ exchanger may be
inhibited. If this were the case, we would expect the recovery of
pHi after a preconditioned ischemia to be
slower than ischemia only.26 Figure 3
illustrates experiments designed to
test this possibility. In 12 experiments, the resting
pHi was 7.41±0.04. In 5 experiments, 30 minutes
of ischemia caused pHi to decline to
6.08±0.17. On reperfusion, pHi recovered rapidly
with an approximately exponential time course as shown in Figure 3A
. The rate of recovery was characterized by the half-time of
recovery, which was 26±5 seconds. In 7 experiments, preconditioned
ischemia was examined, and a representative
record is shown in Figure 3B
. The acidosis in the 5-minute
ischemias is smaller and recovers quickly, and the half-time of
recovery after the first period of ischemia was 17±2 seconds.
In contrast to ischemia only, the acidosis during the
preconditioned ischemia was 6.55±0.18, which is significantly
smaller than the ischemia only (P<0.05, unpaired
t test). Despite the smaller acidosis, the recovery of
acidosis is somewhat slower and the half-time was significantly longer,
at 46±6 seconds. The rate of proton extrusion, which underlies these
pHi recoveries, is a function of
pHi, because both the extrusion mechanisms and
the buffering are pH dependent.27 For this reason, we
also measured the rate of pHi recovery at a
constant pHi (6.8) and obtained the following
values: 5 minutes of ischemia, 0.025±0.002
pHi unit/s, 30 minutes of ischemia only,
0.016±0.002 pH units/s, and preconditioned ischemia,
0.008±0.001 pH units/s. These values are all significantly different
(P<0.001, one-way ANOVA) and confirm the results obtained
with the half-times.
|
| Discussion |
|---|
|
|
|---|
What Causes the [Na+]i Rise During
Ischemia?
Na+ enters the heart by a variety of routes
(channels and exchangers) and is extruded by the
Na+ pump. An increase in
[Na+]i must arise from
increased influx and/or decreased efflux. There is evidence for all
three possibilities during ischemia.
Inhibition of the Na+ Pump
The appearance of an ischemic contracture is usually taken
to mean that the ATP is very low and the Na+ pump
might be expected to inhibited. Strong support for this hypothesis is
provided by Cross et al, 28 who showed that in a low-flow
glucose-free model of ischemia the rise in
[Na+]i occurred only
after the Na+ pump was inhibited. In our
experiments, at 2 Hz, an ischemic contracture is usually not
apparent until relatively late (19 minutes), and we attribute this to
using a low stimulation rate with improved metabolic
status. The Na+ pump therefore remains effective
for longer, and the
[Na+]i is maintained at a
low level for longer in ischemia. Thus, in our present
experiments (2 Hz), we believe that inhibition of the
Na+ pump makes relatively little contribution to
the rise of [Na+]i during
ischemia. In contrast, at 5 Hz, the ischemic
contracture develops much earlier and the rise in
[Na+]i during
ischemia is much larger and presumably reflects inhibition of
the Na+ pump (for discussion see Reference 1717 ).
Entry of Na+ on the Na+/H+
Exchanger
A number of studies have shown that inhibitors of the
Na+/H+ exchanger applied
before ischemia reduce the rate of rise of
[Na+]i during
ischemia.12 13 29 One interpretation of this
observation is that the
Na+/H+ exchanger is active
during ischemia. However, there is strong evidence to suggest
that the Na+/H+ exchanger
is inhibited during ischemia. (1)
[Na+]i does not rise at
the rate one would predict for the degree of acidosis.17
(2) The pHi in ischemia is unaffected by
inhibitors of the
Na+/H+
exchanger.30 13 17 (3) Our earlier17 and
present work show that MIA had no effect on the
[Na+]i during
ischemia. Obviously, if the
Na+/H+ exchanger is
inhibited, it cannot be the cause of the rise of
[Na+]i during
ischemia. An alternative interpretation of the effects of
amiloride on
[Na+]i during
ischemia is that they arise from other effects of these drugs.
Amiloride and even the high-affinity derivatives have many side effects
including blocking Na+ channels.31
Haigney et al21 have suggested that the reduced
[Na+]i during
hypoxia produced by amiloride and its derivatives is caused by
blocking Na+ channels rather than the
Na+/H+ exchanger.
Na+ Entry Through Channels
Haigney et al 21 showed that in rat myocytes the
Na+ rise caused by glucose-free hypoxia
could be reduced by Na+ channel blockers
including 60 µmol/L TTX. More recently, Van Emous et al
22 showed that the increase in
[Na+]i during
ischemia of the rat heart was substantially reduced by 200
µmol/L lidocaine. Note that in both of these studies relatively high
concentrations of drugs were used that would block conventional
INa channels. Our experiments extend these
results by using a low concentration of TTX (100 nmol/L), which would
not be expected to affect INa but instead
would inhibit the
INa(P).23 INa(P)
remains active at the resting potential and is less
inactivated by the depolarization that occurs during
ischemia. In addition, INa(P) is
activated by hypoxia so that its contribution to the
Na+ influx would be expected to rise during
ischemia.24 Thus, in our experiments, the
main cause of the rise of
[Na+]i during
ischemia appears to be Na+ entry though
the persistent Na+ channels. This finding is in
agreement with the demonstration that the
[Na+]i rise during anoxia
is largely through
INa(P).32
Why Does [Na+]i Rise on Reperfusion
After Ischemia?
A number of published studies14 22 29 show that the
[Na+]i falls on
reperfusion, whereas in our study and other studies,12 33
the [Na+]i shows a
transient rise followed by a fall. What is the cause of this
variability between experiments? We suggest that the
Na+ influx on reperfusion is either partly or
completely masked by the activity of the Na+
pump.34 If the
[Na+]i during
ischemia is very high, then the Na+ pump
will be maximally activated when metabolites return to normal
on reperfusion.35 In this case, the
Na+ efflux by the pump will be greater than the
Na+ influx on the exchanger, and the
[Na+]i will fall.
Conversely, if the [Na+]i
during ischemia is low, then the Na+ pump
will have a low efflux rate, and the Na+ influx
from the exchanger will be greater than the efflux, and
[Na+]i will transiently
rise.28
Why Does [Na+]i Not Rise on Reperfusion
in the Preconditioned Heart?
Our second novel finding is that
[Na+]i does not rise on
reperfusion in the preconditioned heart. We have shown that the rise of
[Na+]i after
ischemia is caused by the
Na+/H+ exchanger removing
protons that have accumulated during ischemia. Why does
[Na+]i fail to rise
during reperfusion in the preconditioned heart? (1) If the
preconditioned heart were not acidotic, then there should be no rise of
[Na+]i on reperfusion. It
is generally accepted that the acidosis is smaller in the
preconditioned heart, and this is confirmed by our
data.14 20 36 Typically, the acidosis in the
preconditioned heart is
75% of that in the ischemia-only
heart, so we might expect the
[Na+]i rise on
reperfusion to be reduced to
75% of its previous level, whereas, in
fact, it changed from +11.9 to -3.6 mmol/L. Thus, the difference
in acidosis during ischemia only versus preconditioned
ischemia is not nearly enough to explain the differences in
[Na+]i. (2) An
alternative explanation is that the
Na+/H+ exchanger, which is
believed to be inhibited during ischemia,16 17
remains inhibited during reperfusion in the preconditioned heart. This
possibility is reinforced by the MIA result, in which the mechanical
recovery and [Na+]i
changes are indistinguishable from the preconditioned heart. This
interpretation is strongly supported by our third novel finding
that the rate of recovery of pHi after
ischemia is reduced in the preconditioned heart. Vandenberg et
al26 showed that in the
CO2/HCO3 perfused heart the
Na+/H+ exchanger carried
18% of the proton efflux, the remainder being carried by the
Na+/HCO3-
cotransporter, the lactate transporter, and CO2.
The efflux in our experiments was reduced by
50% by
preconditioning, suggesting that the
Na+/H+ exchanger appears to
be making a greater contribution in our experiments than theirs.
Surprisingly, we observed no increase in
[Na+]i after MIA or
preconditioning, whereas from their observations we would predict a
residual [Na+]i rise
caused by Na+ entry on the
Na+/HCO3-
cotransporter. (3) Another explanation would be that a different proton
extrusion mechanism, which does not cause Na+
loading, has been activated by preconditioning, such as the
vacuolar proton ATPase.37
We conclude that preconditioning appears to cause inhibition of the Na+/H+ exchanger during reperfusion for unknown reasons, and this contributes to protection from ischemic damage. Normally, on reperfusion, the rise of [Na+]i causes Ca2+ entry, and the elevated [Ca2+]i then initiates damage, probably by activating proteases and phospholipases and, in addition, by loading mitochondria with Ca2+ and impairing their function. If preconditioning prevents the rise in [Na+]i, this provides a simple explanation for the protection against damage that preconditioning produces.
What Inhibits the Na+/H+
Exchanger?
It appears from earlier work that the
Na+/H+ exchanger is
inhibited during ischemia. However, the mechanism of this
inhibition is debated. Lazdunski et al 16 initially
suggested that the inhibition arose from the extracellular acidosis,
which is widely agreed to inhibit the exchanger.16 38
During ischemia, there is both an intracellular acidosis, which
activates the exchanger, and an extracellular acidosis, which
inhibits the exchanger. Thus, the net effect depends on the balance of
these opposing effects. We have shown that under conditions that
simulate both the extracellular and the intracellular acidosis of
ischemia the exchanger appears to be active.18 39
Nevertheless, during ischemia, most pH measurements suggest
that the exchanger is inhibited,13 17 30 and our own
measurement of [Na+]i
confirms this view.17 However, the exchanger is also
inhibited by situations in which the metabolic status of
the cardiac cell is reduced,17 40 41 but the nature of the
inhibition is unclear. Simplistically, one could propose a
phosphorylation site required for activation, but Goss
et al41 could find no evidence for a
phosphorylation site that was
dephosphorylated by reduced ATP. Alternatively, one
could propose that ATP has a direct effect on the activity of the
exchanger, but because ATP does not decline rapidly in
ischemia, it is difficult to explain the rapid inhibition of
the Na+/H+ exchanger
observed during ischemia. Furthermore, the
metabolic status of cardiac myocytes improves on
reperfusion, and this recovery is equally evident in preconditioned
hearts as in ischemia only.15 Thus, if the
mechanism by which the
Na+/H+ exchanger is
inhibited during ischemia is low ATP, then one would predict an
equally rapid recovery on reperfusion in the preconditioned heart as in
the ischemic-only heart.
There is a great deal of evidence that activation of protein kinase C during the long ischemia is essential to the protection that occurs on reperfusion.3 4 Thus, one could postulate that protein kinase C phosphorylates the exchanger causing inhibition and that, crucially, this inhibition does not reverse immediately on reperfusion and provides the observed protection against ischemic damage. Current evidence on the role of protein kinase C on the Na+/H+ exchanger is conflicting.42 Alternatively, protein kinase C might phosphorylate a phosphatase that maintains the exchanger dephosphorylated and inactive, and this effect is only reversed slowly on reperfusion. These and other possibilities, such as changes in the expression of the exchanger43 or changes in the distribution of exchanger between surface membrane and internal sites,44 require further investigation.
Significance
The successful protection against reperfusion damage provided by
Na+/H+ exchanger
inhibitors shows the critical role of the
Na+/H+ exchanger in
ischemic damage. Our results suggest that the
endogenous protection provided by preconditioning also
operates by inhibition of the
Na+/H+ exchanger in the
crucial early minutes of reperfusion. One prediction of our results is
that Na+/H+ exchanger
inhibitors will have no effect during ischemia but
exert protection during a critical short period in the first few
minutes of reperfusion.
| Acknowledgments |
|---|
Received January 13, 1999; accepted August 2, 1999.
| References |
|---|
|
|
|---|
2.
Yellon DM, Baxter GF, Garcia-Dorado D, Heusch G,
Sumeray MS. Ischaemic preconditioning: present position and future
directions. Cardiovasc Res. 1998;37:2133.
3.
Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase
C: its role in ischemic preconditioning in the rat. Circ
Res. 1994;75:586590.
4.
Mitchell MB, Meng X, Ao L, Brown JM, Harken AH,
Banerjee A. Preconditioning of isolated rat heart is mediated by
protein kinase C. Circ Res. 1995;76:7381.
5.
Gross GJ, Auchampach JA. Blockade of ATP-sensitive
potassium channels prevents myocardial preconditioning in dogs.
Circ Res. 1992;70:223233.
6.
Liu Y, Gao WD, O'Rourke B, Marbán E.
Synergistic modulation of ATP-sensitive K+
currents by protein kinase C and adenosine: implications for
ischemic preconditioning. Circ Res. 1996;78:443454.
7.
Liu Y, Sato T, O'Rourke B, Marbán E.
Mitochondrial ATP-dependent potassium channels: novel effectors of
cardioprotection? Circulation. 1998;97:24632469.
8. Tani M. Mechanisms of Ca2+ overload in reperfused ischemic myocardium. Annu Rev Physiol. 1990;52:543559.[Medline] [Order article via Infotrieve]
9. Pierce GN, Czubryt MP. The contribution of ionic imbalance to ischemia/reperfusion-induced injury. J Mol Cell Cardiol. 1995;27:5363.[Medline] [Order article via Infotrieve]
10. Poole-Wilson PA, Harding DP, Bourdillon PDV, Tones MA. Calcium out of control. J Mol Cell Cardiol. 1984;16:175187.[Medline] [Order article via Infotrieve]
11.
Karmazyn M. Amiloride enhances postischemic
ventricular recovery: possible role of
Na+-H+ exchange.
Am J Physiol. 1988;255:H608H615.
12.
Tani M, Neely JR. Role of intracellular
Na+ in Ca2+ overload and
depressed recovery of ventricular function of reperfused
ischemic rat hearts: possible involvement of
H+-Na+ and
Na+-Ca2+ exchange.
Circ Res. 1989;65:10451056.
13.
Murphy E, Perlman M, London RE, Steenbergen C.
Amiloride delays the ischemia-induced rise in cytosolic free
calcium. Circ Res. 1991;68:12501258.
14.
Steenbergen C, Perlman M, London RE, Murphy E.
Mechanism of preconditioning: ionic alterations. Circ Res. 1993;72:112125.
15.
Murry CE, Richard VJ, Reimer KA, Jennings RB.
Ischemic preconditioning slows energy metabolism
and delays ultrastructural damage during a sustained ischemic
episode. Circ Res. 1990;66:913930.
16. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol. 1985;17:10291042.[Medline] [Order article via Infotrieve]
17.
Park CO, Xiao XH, Allen DG. Changes in intracellular
Na+ and pH in rat heart during ischemia:
role of Na+/H+ exchanger.
Am J Physiol. 1999;276:H1581H1590.
18.
Turvey SE, Allen DG. Changes in myoplasmic sodium
concentration during exposure to lactate in perfused rat heart.
Cardiovasc Res. 1994;28:987993.
19.
Case RB, Felix A, Castellana FS. Rate of rise of
myocardial PCO2 during early
myocardial ischemia in the dog. Circ Res. 1979;45:324330.
20. Liu H, Cala PM, Anderson SE. Ischemic preconditioning: effects on pH, Na and Ca in newborn rabbit hearts during ischemia/reperfusion. J Mol Cell Cardiol. 1998;30:685697.[Medline] [Order article via Infotrieve]
21.
Haigney MC, Lakatta EG, Stern MD, Silverman HS. Sodium
channel blockade reduces hypoxic sodium loading and sodium-dependent
calcium loading. Circulation. 1994;90:391399.
22. Van Emous J, Nederhoff MG, Ruigrok TJ, Van Echteld C. The role of the Na+ channel in the accumulation of intracellular Na+ during myocardial ischemia: consequences for post-ischemic recovery. J Mol Cell Cardiol. 1997;29:8596.[Medline] [Order article via Infotrieve]
23.
Saint DA, Ju YK, Gage PW. A persistent sodium current
in rat ventricular myocytes. J Physiol
(Lond). 1992;453:219231.
24.
Ju YK, Saint DA, Gage PW. Hypoxia increases
persistent sodium current in rat ventricular myocytes.
J Physiol (Lond). 1996;497:337347.
25.
Maier LS, Pieske B, Allen DG. Influence of stimulation
frequency on [Na+]i and
contractile function in Langendorff-perfused rat heart. Am J
Physiol. 1997;273:H1246H1254.
26.
Vandenberg JI, Metcalfe JC, Grace AA. Mechanisms of
pHi recovery after global ischemia in the
perfused heart. Circ Res. 1993;72:9931003.
27.
Vaughan-Jones RD, Wu ML. pH dependence of intrinsic
H+ buffering in the sheep cardiac Purkinje fibre.
J Physiol (Lond). 1990;425:429448.
28. Cross HR, Radda GK, Clarke K. The role of Na+/K+ ATPase activity during low flow ischemia in preventing myocardial injury: a 31P, 23Na and 87Rb NMR spectroscopic study. Magn Reson Med. 1995;34:673685.[Medline] [Order article via Infotrieve]
29. Liu H, Cala PM, Anderson SE. Ethylisopropylamiloride diminishes changes in intracellular Na, Ca and pH in ischemic newborn myocardium. J Mol Cell Cardiol. 1997;29:20772086.[Medline] [Order article via Infotrieve]
30. Imai S, Shi AY, Ishibashi T, Nakazawa M. Na +/H+ exchange is not operative under low-flow ischemic conditions. J Mol Cell Cardiol. 1991;23:505517.[Medline] [Order article via Infotrieve]
31. Kleyman TR, Cragoe EJ. Amiloride and its analogs as tools in the study of ion transport. J Membr Biol. 1988;105:121.[Medline] [Order article via Infotrieve]
32. Russ U, Balser C, Scholz W, Albus U, Lang HJ, Weichert A, Scholkens BA, Gogelein H. Effects of the Na+/H+-exchange inhibitor Hoe 642 on intracellular pH, calcium and sodium in isolated rat ventricular myocytes. Pflugers Arch. 1996;433:2634.[Medline] [Order article via Infotrieve]
33.
Panagiotopoulos S, Daly MJ, Nayler WG. Effect of
acidosis and alkalosis on postischemic Ca gain in isolated
rat heart. Am J Physiol. 1990;258:H821H828.
34. Van Emous J, Schreur JH, Ruigrok TJ, Van Echteld C. Both Na+-K+ ATPase and Na+-H+ exchanger are immediately active upon post-ischemic reperfusion in isolated rat hearts. J Mol Cell Cardiol. 1998;30:337348.[Medline] [Order article via Infotrieve]
35. Eisner DA, Smith TW. The Na-K pump and its effectors in cardiac muscle. In: Fozzard HA, Haber E, Jennings RB, Katz A, Morgan HE, eds. The Heart and Cardiovascular System: Scientific Foundations. New York, NY: Raven Press; 1991:863902.
36.
Kida M, Fujiwara H, Ishida M, Kawai C, Ohura M, Miura
I, Yabuuchi Y. Ischemic preconditioning preserves creatine
phosphate and intracellular pH. Circulation. 1991;84:24952503.
37. Gottlieb RA, Gruol DL, Zhu JY, Engler RL. Preconditioning in rabbit cardiomyocytes. Role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest. 1996;97:23912398.[Medline] [Order article via Infotrieve]
38.
Vaughan-Jones RD, Wu ML. Extracellular
H+ inactivation of Na+-H
+ exchange in the sheep cardiac Purkinje fibre.
J Physiol (Lond). 1990;428:441466.
39.
Cairns SP, Westerblad H, Allen DG. Changes in
myoplasmic pH and calcium concentration during exposure to lactate in
isolated rat ventricular myocytes. J Physiol
(Lond). 1993;464:561574.
40.
Weissberg PL, Little PJ, Cragoe EJJ, Bobik A. The pH of
spontaneously beating cultured rat heart cells is regulated by an
ATP-calmodulin-dependent
Na+/H+ antiport. Circ
Res. 1989;64:676685.
41.
Goss GG, Woodside M, Wakabayashi S, Pouyssegur J,
Waddell T, Downey GP, Grinstein S. ATP dependence of NHE-1, the
ubiquitous isoform of the
Na+/H+ antiporter.
Analysis of phosphorylation and subcellular
localization. J Biol Chem. 1994;269:87418748.
42. Fliegel L, Wang H. Regulation of the Na+/H+ exchanger in the mammalian myocardium. J Mol Cell Cardiol. 1997;29:19911999.[Medline] [Order article via Infotrieve]
43. Dyck JR, Maddaford TG, Pierce GN, Fliegel L. Induction of expression of the sodium-hydrogen exchanger in rat myocardium. Cardiovasc Res. 1995;29:203208.[Medline] [Order article via Infotrieve]
44.
Kurashima K, Szabo EZ, Lukacs G, Orlowski J, Grinstein
S. Endosomal recycling of the
Na+/H+ exchanger NHE3
isoform is regulated by the phosphatidylinositol 3-kinase pathway.
J Biol Chem. 1998;273:2082820836.
This article has been cited by other articles:
![]() |
G.-Y. Song, Y.-J. Wu, Y.-J. Yang, J.-J. Li, H.-L. Zhang, H.-J. Pei, Z.-Y. Zhao, Z.-H. Zeng, and R.-T. Hui The accelerated post-infarction progression of cardiac remodelling is associated with genetic changes in an untreated streptozotocin-induced diabetic rat model Eur J Heart Fail, October 1, 2009; 11(10): 911 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, M. Whiteman, Y. Y. Guan, K. L. Neo, Y. Cheng, S. W. Lee, Y. Zhao, R. Baskar, C.-H. Tan, and P. K. Moore Characterization of a Novel, Water-Soluble Hydrogen Sulfide-Releasing Molecule (GYY4137): New Insights Into the Biology of Hydrogen Sulfide Circulation, May 6, 2008; 117(18): 2351 - 2360. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Iwata, Y. Katanosaka, T. Hisamitsu, and S. Wakabayashi Enhanced Na+/H+ Exchange Activity Contributes to the Pathogenesis of Muscular Dystrophy via Involvement of P2 Receptors Am. J. Pathol., November 1, 2007; 171(5): 1576 - 1587. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Saini and N. S. Dhalla Sarcolemmal cation channels and exchangers modify the increase in intracellular calcium in cardiomyocytes on inhibiting Na+-K+-ATPase Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H169 - H181. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hale, J. A. Leeka, and R. A. Kloner Improved Left Ventricular Function and Reduced Necrosis after Myocardial Ischemia/Reperfusion in Rabbits Treated with Ranolazine, an Inhibitor of the Late Sodium Channel J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 418 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Pedersen, M. E. O'Donnell, S. E. Anderson, and P. M. Cala Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Cl- cotransport in the heart, brain, and blood Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R1 - R25. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Belardinelli, J C Shryock, and H Fraser Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine Heart, July 1, 2006; 92(suppl_4): iv6 - iv14. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Davies, S. B. Digerness, S. P. Goldberg, C. R. Killingsworth, C. R. Katholi, P. S. Brookes, and W. L. Holman Intra-myocyte ion homeostasis during ischemia-reperfusion injury: effects of pharmacologic preconditioning and controlled reperfusion Ann. Thorac. Surg., October 1, 2003; 76(4): 1252 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Digerness, P. S. Brookes, S. P. Goldberg, C. R. Katholi, and W. L. Holman Modulation of mitochondrial adenosine triphosphate-sensitive potassium channels and sodium-hydrogen exchange provide additive protection from severe ischemia-reperfusion injury J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 863 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M Bers, W. H Barry, and S. Despa Intracellular Na+ regulation in cardiac myocytes Cardiovasc Res, March 15, 2003; 57(4): 897 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G Allen and X.-H. Xiao Role of the cardiac Na+/H+ exchanger during ischemia and reperfusion Cardiovasc Res, March 15, 2003; 57(4): 934 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Rothstein, K. L. Byron, R. E. Reed, L. Fliegel, and P. A. Lucchesi H2O2-induced Ca2+ overload in NRVM involves ERK1/2 MAP kinases: role for an NHE-1-dependent pathway Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H598 - H605. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kohin, C. M. Stary, R. A. Howlett, and M. C. Hogan Preconditioning improves function and recovery of single muscle fibers during severe hypoxia and reoxygenation Am J Physiol Cell Physiol, July 1, 2001; 281(1): C142 - C146. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Knight, A. H. Smith, D. M. Flynn, J. T. MacAndrew, S. S. Ellery, J. X. Kong, R. B. Marala, R. T. Wester, A. Guzman-Perez, R. J. Hill, et al. A Novel Sodium-Hydrogen Exchanger Isoform-1 Inhibitor, Zoniporide, Reduces Ischemic Myocardial Injury in Vitro and in Vivo J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 254 - 259. [Abstract] [Full Text] |
||||
![]() |
M. Avkiran, G. Gross, M. Karmazyn, H. Klein, E. Murphy, and K. Ytrehus Na+/H+ exchange in ischemia, reperfusion and preconditioning Cardiovasc Res, April 1, 2001; 50(1): 162 - 163. [Full Text] [PDF] |
||||
![]() |
D. G Allen and X.-h. Xiao Na+ entry during ischemia, reperfusion and preconditioning Cardiovasc Res, April 1, 2001; 50(1): 164 - 166. [Full Text] [PDF] |
||||
![]() |
J. W.T Fiolet Reperfusion injury and ischemic preconditioning: two sides of a coin? Cardiovasc Res, November 1, 2000; 48(2): 185 - 187. [Full Text] [PDF] |
||||
![]() |
X-H. Xiao and D.G. Allen Activity of the Na+/H+ exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart Cardiovasc Res, November 1, 2000; 48(2): 244 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. El Banani, M. Bernard, D. Baetz, E. Cabanes, P. Cozzone, A. Lucien, and D. Feuvray Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine: Comparison between low- and zero-flow ischaemia Cardiovasc Res, September 1, 2000; 47(4): 688 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. FINK, S. ERGÜN, D. KRALISCH, U. REMMERS, J. WEIL, and T. ESCHENHAGEN Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement FASEB J, April 1, 2000; 14(5): 669 - 679. [Abstract] [Full Text] |
||||
![]() |
K. Imahashi, T. Nishimura, J. Yoshioka, and H. Kusuoka Role of Intracellular Na+ Kinetics in Preconditioned Rat Heart Circ. Res., June 8, 2001; 88(11): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |